Stay updated on Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial
Sign up to get notified when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.

Latest updates to the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 added, and the lapse-in-funding notice and Revision: v3.4.1 were removed. The study details and page content remain unchanged.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedThe updates are limited to UI/text changes and page revision metadata (e.g., Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) with no changes to the underlying study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision changed from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a 'Locations' section showing Maryland as a study location. Removed the 'Maryland Locations' entry and the 'HHS Vulnerability Disclosure' footer link.SummaryDifference0.2%

- Check77 days agoChange DetectedThe page shows December 2025 update dates and corresponding November 2025 deletions, indicating administrative edits to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.